Rgs1-flox Mouse

Rgs1, short for Regulator of G-protein signaling 1, is a gene involved in multiple biological processes. It plays a role in regulating G-protein-coupled receptor (GPCR) signaling, which is crucial for various cellular functions such as cell communication, signal transduction, and cell response to stimuli [7]. Dysregulation of Rgs1 has implications in numerous disease conditions.

In alveolar macrophages, Rgs1 coregulates the immunophenotype of subpopulations through the PLC-IP3R signal-dependent intracellular Ca2+ response. Epithelium-and endothelium-derived exosomes target RGS1 expression, and imbalance of alveolar macrophages due to RGS1 dysregulation is linked to acute lung injury/acute respiratory distress syndrome (ALI/ARDS) and pulmonary fibrosis (PF) [1].

In renal interstitial fibrosis (RIF), RGS1 expression is elevated, and knockdown of RGS1 inhibits renal cell inflammatory response, fibrosis, and renal fibrosis in RIF mice, suggesting it mediates RIF through activation of the inflammatory response [2].

In cervical cancer, RGS1 is associated with the immune microenvironment and cell function. Knockdown of RGS1 in cervical cancer cell lines inhibits cell proliferation, migration, invasion, and tumor growth in nude mice and promotes apoptosis, indicating it may be a target for immunotherapy [3].

In gastric cancer, silencing the RGS1 gene reduces the proliferation of drug-resistant cells in vitro and inhibits tumor growth in vivo, making it an antitumor target [4].

In osteosarcoma, RGS1 is a tumor-promoting gene, and microRNA-376b-3p can target RGS1 to inhibit cell proliferation, metastasis, and apoptosis [6].

In spinal cord injury, inhibiting RGS1 attenuates secondary inflammation response and tissue degradation via the TLR/TRIF/NF-κB pathway in macrophages [5].

In summary, Rgs1 is involved in regulating immune responses, inflammation, and cell functions in various tissues. The use of gene knockdown and mouse models in these studies has revealed its significance in diseases like ALI/ARDS, PF, RIF, cervical cancer, gastric cancer, osteosarcoma, and spinal cord injury, highlighting its potential as a therapeutic target in these disease areas.